Dr. Van Goor received his Ph.D. and B.Sc. from the University of Alberta, Canada. In 2001, Dr. Van Goor joined Vertex Pharmaceuticals to help identify new medicines for the treatment of cystic fibrosis.
Navigating the Past, Present, and Future of CFTR Dysfunction Through Sweat Chloride
Friday, October 24, 2025
12:30 PM - 1:30 PM PDT